FERRARESE, Mattia
 Distribuzione geografica
Continente #
NA - Nord America 1.843
AS - Asia 726
EU - Europa 648
SA - Sud America 59
AF - Africa 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.283
Nazione #
US - Stati Uniti d'America 1.824
SG - Singapore 283
CN - Cina 242
IT - Italia 231
DE - Germania 102
PL - Polonia 58
TR - Turchia 57
UA - Ucraina 56
ID - Indonesia 55
BR - Brasile 52
FI - Finlandia 42
GB - Regno Unito 40
SE - Svezia 32
CZ - Repubblica Ceca 17
BE - Belgio 15
HK - Hong Kong 14
CA - Canada 13
PK - Pakistan 12
JP - Giappone 10
NO - Norvegia 10
VN - Vietnam 10
IN - India 9
IR - Iran 9
FR - Francia 8
NL - Olanda 8
RU - Federazione Russa 8
KR - Corea 6
MX - Messico 5
PT - Portogallo 5
GE - Georgia 4
AT - Austria 3
DK - Danimarca 3
EC - Ecuador 3
IE - Irlanda 3
IQ - Iraq 3
ZA - Sudafrica 3
AR - Argentina 2
AU - Australia 2
BD - Bangladesh 2
CL - Cile 2
IL - Israele 2
LT - Lituania 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
ES - Italia 1
EU - Europa 1
GT - Guatemala 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
RO - Romania 1
TN - Tunisia 1
Totale 3.283
Città #
Chandler 212
Fairfield 195
Santa Clara 167
Singapore 161
Woodbridge 131
Ferrara 110
Ashburn 103
Seattle 83
Houston 72
Wilmington 71
Cambridge 67
Ann Arbor 64
Warsaw 57
New York 54
Jakarta 52
Izmir 46
Jacksonville 43
Princeton 43
Shanghai 39
Nanjing 37
Dearborn 34
Beijing 33
Helsinki 30
Milan 26
Bremen 22
Los Angeles 20
Nanchang 15
Brno 13
Redwood City 12
Falkenstein 11
Guangzhou 11
San Diego 11
Brussels 10
Dong Ket 10
Lahore 10
Munich 10
Shenyang 10
The Dalles 10
Toronto 10
Boardman 9
Bologna 9
Hebei 9
Hong Kong 9
Jiaxing 8
Rome 8
London 7
Oslo 7
Zhengzhou 7
Chicago 6
Fairford 6
Kunming 6
Piemonte 6
Andover 5
Ferrara di Monte Baldo 5
Jinan 5
San Mateo 5
São Paulo 5
Tianjin 5
Turku 5
Washington 5
Brooklyn 4
Cagliari 4
Castagnole delle Lanze 4
Changsha 4
Des Moines 4
Erlangen 4
Indore 4
Louvain 4
Ningbo 4
Nuremberg 4
Seocho-gu 4
Atlanta 3
Chengdu 3
Copenhagen 3
Florence 3
Frankfurt am Main 3
Hangzhou 3
Ipiranga 3
Krasnodar 3
Leawood 3
Moscow 3
Norwalk 3
Olomouc 3
Reading 3
Rio de Janeiro 3
San Francisco 3
Silveira 3
Tokyo 3
Alexandria 2
Augusta 2
Belvedere Spinello 2
Calcinato 2
Chapel Hill 2
Clifton 2
Dallas 2
Dublin 2
Duncan 2
Falls Church 2
Fars 2
Halesowen 2
Totale 2.371
Nome #
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 195
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth 170
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics 150
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 146
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 143
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 124
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 123
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 115
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 114
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 111
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 107
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 99
null 93
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 93
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants 87
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 87
An optimized in vitro expression platform identifies Haemophilia B nonsense mutations, and thus patients, eligible for therapeutic drug-induced readthrough 86
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I 86
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 82
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics 75
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia 73
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 72
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 71
Protein engineering and pharmacological approaches to develop novel treatment strategies for coagulation disorders 71
Rational engineering of a novel factor IX albumin fusion protein results in enhanced coagulant activity and pharmacokinetic profile 68
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity 66
Identification of novel mechanisms underlying functional response to drug-induced readthrough of haemophilia B nonsense mutations 66
Design of a novel factor IX albumin fusion protein with enhanced coagulant activity and pharmacokinetic profile 65
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 64
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 61
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 60
Next generation factor VIIa with enhanced half-life 56
An advanced method for the small-scale production of high-quality minicircle DNA 54
Design of a novel factor IX variant with enhanced procoagulant activity and half-life 51
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 47
Recombinant Expression of F9 Nonsense Mutations and Fix Pharmacokinetics in Hemophilia B 45
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 44
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains 41
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 41
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 27
Totale 3.429
Categoria #
all - tutte 21.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 0 0 0 0 16 9
2020/2021433 19 9 22 24 20 38 58 60 25 66 51 41
2021/2022358 59 35 8 4 21 22 5 12 17 31 21 123
2022/2023436 48 61 12 62 62 50 30 31 42 5 18 15
2023/2024285 10 23 16 4 17 61 15 30 6 9 12 82
2024/2025893 36 20 97 29 130 167 20 23 178 103 90 0
Totale 3.429